跳至主要内容
临床试验/NCT05133778
NCT05133778已完成不适用

The Effect of Sweet Orange and Pomegranate Extract Supplementation on Exercise Capacity: a Randomized Controlled Parallel Intervention Study in Healthy Overweight Individuals

Maastricht University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2021年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
1
主要终点
Change in endurance capacity

研究概览

简要总结

The aim of the present study is to investigate the effect of 12-week long daily administration of a sweet orange and pomegranate extract on exercise capacity in healthy adults.

详细描述

Background of the study: Polyphenols have been studied for their protective effect against the development of ROS-related diseases like cancers, cardiovascular diseases, diabetes, osteoporosis, and neurodegenerative diseases. The combined supplementation of pomegranate and sweet orange polyphenols could be an effective strategy to improve exercise performance, due to their antioxidant character and ability to stimulate NO production, to stimulate mitochondrial biogenesis and to accelerate muscle repair and decrease muscle tissue damage. The study aims to assess the effect of a combined supplementation of pomegranate and sweet orange extract on exercise capacity, physical activity, muscle strength and quality of life in healthy adults.

Objective of the study: The aim of the present study is to investigate the effect of 12-week long daily administration of a sweet orange and pomegranate extract on exercise capacity in healthy adults (40 - 65 y).

Study design: Randomized, double-blind, placebo-controlled parallel trial

Study population: Healthy, overweight, sedentary adults between 40 and 65 years old.

Intervention: 12-week supplementation with 650 mg sweet orange and pomegranate extract (2 capsules per day) compared to placebo (760 mg maltodextrin).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Healthy male/female (based on medical history provided during a general health questionnaire)
  • •Age between 40 - 65 yrs
  • •Overweight (BMI ≥25 to ≤29.9 kg/m2)
  • •Sedentary subjects (Low Level [<600 MET-minutes/week] as assessed by the Physical Activity Questionnaire (IPAQ))

排除标准

  • •Allergy to test product/control or citrus fruits and pomegranate
  • •Medical conditions that might interfere with endpoints or compromise participant safety during testing (e.g. Cardiovascular diseases, cancer, Parkinson's disease, Gastrointestinal diseases or abdominal surgery) to be decided by the principal investigator
  • •Use of medication that might interfere with endpoints (i.e.: β-blockers, antioxidant, antidepressants)
  • •High fasting blood glucose (FBG ≥100 mg/dL)
  • •Recent skeletal muscle injury in less than one month before the start of the study
  • •Use of antibiotics within 3 months prior to Visit 2
  • •Use of probiotics or supplements containing vitamins, minerals or antioxidants four weeks prior to Visit 2
  • •Regular smoking (including use of e-cigarettes)
  • •Inability to correctly perform the PA test during screening/familiarization
  • •Abuse of alcohol (alcohol consumption >20 units/week) and/or drugs
  • •Plans to change diet or medication for the duration of the study
  • •Treatment with an investigational drug (phase 1-3) 180 days before the start of the study
  • •Inability to understand study information and/or communicate with staff

研究组 & 干预措施

Sweet orange and pomegranate extract

Experimental

Supplementation

干预措施: Sweet orange and pomegranate extract (Dietary Supplement)

Maltodextrin

Placebo Comparator

Supplementation

干预措施: Maltodextrin control (Other)

结局指标

主要结局

Change in endurance capacity

时间窗: 12 weeks

An Ekblom-bak cycling test is used to estimate the maximal oxygen consumption

次要结局

  • Change in Muscle metabolism (marker Glut4)(12 weeks)
  • Change in Muscle redox biology (marker GCLC)(12 weeks)
  • Change in Muscle redox biology (marker Hmox1)(12 weeks)
  • Change in Daily physical activity(12 weeks)
  • Change in Handgrip strength(12 weeks)
  • Change in Muscle mitochondrial biogenesis (marker PGC1alpha)(12 weeks)
  • Change in Self reported quality of life(12 weeks)
  • Change in General health(12 weeks)
  • Change in Vitality(12 weeks)
  • Change in Glucose levels(12 weeks)
  • Change in Cholesterol levels(12 weeks)
  • Change in Triglyceride levels(12 weeks)
  • Change in Insulin levels(12 weeks)
  • Change in Muscle proliferation (marker Pax7)(12 weeks)
  • Change in Muscle differentiation (marker MyoD)(12 weeks)
  • Change in Muscle differentiation (marker Myogenin)(12 weeks)
  • Change in Muscle differentiation (marker Myosin Heavy Chain)(12 weeks)
  • Change in Antioxidative capacity(12 weeks)
  • Change in Cell elongation index(12 weeks)
  • Change in Cortisol levels(12 weeks)
  • Change in C-reactive protein levels(12 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验